After quantification of immunohistochemical stainings of 76 patients, we found that the expressions of IL-17A were higher in patients with lymph node metastasis of N1 and N2 stages [29] than N0 (without metastasis) stage (Figure 2E). The gene discussed is IL17A; the disease is metastatic malignant neoplasm in the lymph nodes.